Publicacións en colaboración con investigadores/as de Monash University (15)

2023

  1. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry

    European journal of preventive cardiology, Vol. 30, Núm. 13, pp. 1346-1358

2022

  1. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

2021

  1. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

2020

  1. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

    European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392

  2. International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients

    JACC: Heart Failure, Vol. 8, Núm. 3, pp. 212-222

2018

  1. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 20, Núm. 1, pp. 16-37

2017

  1. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

    Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 162-171

  2. Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart failure: Results from the ESC-HFA Heart Failure Long-Term Registry

    Diabetes Care

  3. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 19, Núm. 10, pp. 1242-1254

  4. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 19, Núm. 12, pp. 1574-1585

  5. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 19, Núm. 1, pp. 54-65

2016

  1. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 18, Núm. 7, pp. 859-868

  2. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy

    European Journal of Heart Failure, Vol. 18, Núm. 9, pp. 1096-1105

  3. European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

    European Journal of Heart Failure, Vol. 18, Núm. 6, pp. 613-625

2015

  1. Polymer-free drug-coated coronary stents in patients at high bleeding risk

    New England Journal of Medicine, Vol. 373, Núm. 21, pp. 2038-2047